Merck & Co., Inc. Price Chart
Merck & Co., Inc. MRKCL.SN Financial and Trading Overview
| Merck & Co., Inc. stock price | 121390 CLP |
| Previous Close | 77794 CLP |
| Open | 0 CLP |
| Bid | 0 CLP x N/A |
| Ask | 0 CLP x N/A |
| Day's Range | 0 - 0 CLP |
| 52 Week Range | 0 - 99040 CLP |
| Volume | 0 CLP |
| Avg. Volume | 1 CLP |
| Market Cap | N/A |
| Beta (5Y Monthly) | 0.357746 |
| PE Ratio (TTM) | 15458.923 |
| EPS (TTM) | 5.59 CLP |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
MRKCL.SN Valuation Measures
| Enterprise Value | 299.04B CLP |
| Trailing P/E | 15458.923 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 4679.471 |
| Enterprise Value/Revenue | 5.168 |
| Enterprise Value/EBITDA | 13.37 |
Trading Information
Merck & Co., Inc. Stock Price History
| Beta (5Y Monthly) | 0.357746 |
| 52-Week Change | 0% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 99040 CLP |
| 52 Week Low | 0 CLP |
| 50-Day Moving Average | 77794 CLP |
| 200-Day Moving Average | 77794 CLP |
MRKCL.SN Share Statistics
| Avg. Volume (3 month) | 1 CLP |
| Avg. Daily Volume (10-Days) | 3 CLP |
| Shares Outstanding | N/A |
| Float | 2.53B |
| Short Ratio | N/A |
| % Held by Insiders | 0.088% |
| % Held by Institutions | 77.43% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 2.8 |
| Trailing Annual Dividend Yield | 0.0035% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 22.51% |
| Operating Margin (ttm) | 32.31% |
| Gross Margin | 72.75% |
| EBITDA Margin | 38.65% |
Management Effectiveness
| Return on Assets (ttm) | 10.89% |
| Return on Equity (ttm) | 29.69% |
Income Statement
| Revenue (ttm) | 57.87B CLP |
| Revenue Per Share (ttm) | 22.83 CLP |
| Quarterly Revenue Growth (yoy) | -8.90% |
| Gross Profit (ttm) | 42.08B CLP |
| EBITDA | 22.37B CLP |
| Net Income Avi to Common (ttm) | 13.03B CLP |
| Diluted EPS (ttm) | 5.587 |
| Quarterly Earnings Growth (yoy) | -34.50% |
Balance Sheet
| Total Cash (mrq) | 10.39B CLP |
| Total Cash Per Share (mrq) | 4.09 CLP |
| Total Debt (mrq) | 30.75B CLP |
| Total Debt/Equity (mrq) | 65.55 CLP |
| Current Ratio (mrq) | 1.444 |
| Book Value Per Share (mrq) | 18.457 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 15.67B CLP |
| Levered Free Cash Flow (ttm) | 9.5B CLP |
Profile of Merck & Co., Inc.
| Country | Chile |
| State | NJ |
| City | Rahway |
| Address | 126 East Lincoln Avenue |
| ZIP | 07065 |
| Phone | 908 740 4000 |
| Website | https://www.merck.com |
| Industry | |
| Sector(s) | |
| Full Time Employees | 67000 |
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. The company serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. It has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics LP; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Rahway, New Jersey.
Q&A For Merck & Co., Inc. Stock
What is a current MRKCL.SN stock price?
Merck & Co., Inc. MRKCL.SN stock price today per share is 121390 CLP.
How to purchase Merck & Co., Inc. stock?
You can buy MRKCL.SN shares on the Santiago exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Merck & Co., Inc.?
The stock symbol or ticker of Merck & Co., Inc. is MRKCL.SN.
How many shares does Merck & Co., Inc. have in circulation?
The max supply of Merck & Co., Inc. shares is 0.
What is Merck & Co., Inc. Price to Earnings Ratio (PE Ratio)?
Merck & Co., Inc. PE Ratio is 21727.22500000 now.
What was Merck & Co., Inc. earnings per share over the trailing 12 months (TTM)?
Merck & Co., Inc. EPS is 5.59 CLP over the trailing 12 months.